IL10 and neoplasm: Tumors, in turn, inhibit this anti-tumor activity by producing immunosuppressive cytokines, such as IL-10 and TNF-β, and inducing immunosuppressive cells, such as Tregs, tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSC) [21–24].